Saringer Life Science Technologies Inc. Offers Investors Excellent Prospects

Saringer Life Science Technologies Inc.(SLST Inc.) offers investors a great opportunity to invest in a growing innovative medical technology company with impressive potential.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Saringer Life Science Technologies
Saringer Life Science Technologies Inc. is a medical device company providing innovative therapeutic solutions for patients.

Toronto, Canada (PRWEB) June 12, 2012

Saringer Life Science Technologies Inc. (SLST) is a Canadian manufacturer and distributor of medical devices. Launched in 2007, SLST has focused its efforts on two of its most advanced medical innovations to date; The Venowave and The ICE-O-therm. After years of clinical studies and product testing both products are market ready utilizing the latest state of the art technology (IP protected). The products have a broad range of approved indications including pain treatment, preventing blood clotting or Deep Vein Thrombosis (DVT), and a broad range of vascular conditions including the most severe; Post Thrombotic Syndrome (PTS). Many of these conditions are largely unmet clinical needs.

To date, the company has published four major clinical studies in conjunction with McMaster University, a world leading research institution located in Hamilton ON Canada. SLST also has two additional studies in development. In 2007, SLST launched their successful product; The Venowave VW5, a mobile sequential compression pump for individuals suffering from Chronic Venous Insufficiency (CVI) & Post Thrombotic Syndrome (PTS). Since its release, the company discovered that their revolutionary product also had statistically reduced the prevalence of Deep Vein Thrombosis (DVT) in high risk patients and has an effect on wound healing & PAD (peripheral arterial disease). After several studies, results confirmed there is enormous potential in these two new massive medical markets. The company’s products have received a CE mark across Europe, FDA approval in the USA, and Health Canada certification, additionally, the organization is ISO 13485 compliant.

Currently, Saringer Life Science Technologies Inc. is looking for financing for the international commercialization of its products. "This is probably one of the most exciting times for an investor to make an entrance at SLST. Our products are commercial ready with inventory on shelf, solid clinical publications and backing by leading surgeons and physicians. Our organization is ready to launch a full out patient marketing program and begin to sell our products." President and Chief Executive Officer John Saringer details.

Saringer Life Science Technologies is a privately-owned company that was founded by engineer/inventor, John Saringer. John works extensively with leading physicians/surgeons in the development of new and improved medical treatment devices in the fields of DVT prevention, vascular solutions, wound healing intervention and pain management. For more information, please call 905.888.1888.